Potential interventions for novel coronavirus in China: A systematic review, J. Med. Virol, vol.2020, pp.479-490 ,
2019-nCoV transmission through the ocular surface must not be ignored, Lancet Lond. Engl, vol.395, p.39, 2020. ,
Consistent detection of 2019 novel coronavirus in saliva, Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am, 2020. ,
Transmission routes of 2019-nCoV and controls in dental practice, Int. J. Oral Sci, vol.12, p.9, 2020. ,
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients, N. Engl. J. Med, vol.382, pp.1177-1179, 2020. ,
The oral microbiome: A Lesson in coexistence, PLoS Pathog, vol.14, p.1006719, 2018. ,
Acquiring and maintaining a normal oral microbiome: current perspective. Front, Cell. Infect. Microbiol, vol.4, p.85, 2014. ,
Oral microbiome: Unveiling the fundamentals, J. Oral Maxillofac. Pathol. JOMFP, vol.23, pp.122-128, 2019. ,
Oral Microbiome: A New Biomarker Reservoir for Oral and Oropharyngeal Cancers, vol.7, pp.4313-4321, 2017. ,
Effect of pH and temperature on the infectivity of human coronavirus 229E, Can. J. Microbiol, vol.35, pp.972-974, 1989. ,
Human coronaviruses: insights into environmental resistance and its influence on the development of new antiseptic strategies, Viruses, vol.4, pp.3044-3068, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-01650388
The role of natural salivary defences in maintaining a healthy oral microbiota, J. Dent, vol.80, issue.1, pp.3-12, 2019. ,
,
Prospective, randomised, controlled study evaluating early modification of oral microbiota following admission to the intensive care unit and oral hygiene with chlorhexidine, J. Glob. Antimicrob. Resist, vol.8, pp.159-163, 2017. ,
Bacterial biofilm formation on implantable devices and approaches to its treatment and prevention, 1067. ,
Biofilm-specific antibiotic resistance, Future Microbiol, vol.7, pp.1061-1072, 2012. ,
The buccale puzzle: The symbiotic nature of endogenous infections of the oral cavity. Can, J. Infect. Dis. J. Can. Mal. Infect, vol.13, pp.34-41, 2002. ,
MAIT cells launch a rapid, robust and distinct hyperinflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: Defining a novel mechanism of superantigen-induced immunopathology and immunosuppression, PLoS Biol, p.2001930, 2017. ,
New Viral Facets in Oral Diseases: The EBV Paradox, Int. J. Mol. Sci, p.5861, 1920. ,
Porphyromonas gingivalis induces CCR5-dependent transfer of infectious HIV-1 from oral keratinocytes to permissive cells, Retrovirology, vol.5, p.29, 2008. ,
Nanoparticles as Anti-Microbial, Anti-Inflammatory, and Remineralizing Agents in Oral Care Cosmetics: A Review of the Current Situation, Nanomater. Basel Switz, vol.10, p.140, 2020. ,
URL : https://hal.archives-ouvertes.fr/hal-02448042
The effect of mouthrinses on oral malodor: a systematic review, Int. J. Dent. Hyg, vol.10, pp.209-222, 2012. ,
Evidence-based strategy for dental biofilms: Current evidence of mouthwashes on dental biofilm and gingivitis, Jpn. Dent. Sci. Rev, vol.55, pp.33-40, 2019. ,
Oropharyngeal colonization: epidemiology, treatment and ventilator-associated pneumonia prevention, Ann. Transl. Med, vol.6, p.426, 2018. ,
Chlorhexidine: expanding the armamentarium for infection control and prevention, Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am, vol.46, pp.274-281, 2008. ,
Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia, Cochrane Database Syst. Rev, vol.10, p.8367, 2016. ,
Influence of different postinterventional maintenance concepts on periodontal outcomes: an evaluation of three systematic reviews, BMC Oral Health, vol.17, p.19, 2016. ,
An in vitro oral biofilm model for comparing the efficacy of antimicrobial mouthrinses, Caries Res, vol.36, pp.93-100, 2002. ,
Nanoparticle-Encapsulated Chlorhexidine against Oral Bacterial Biofilms, PLOS ONE, vol.9, p.103234, 2014. ,
Flavonoids: an overview, J. Nutr. Sci, vol.5, p.47, 2016. ,
The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer, Pharmacol. Rev, vol.52, pp.673-751, 2000. ,
The flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor alpha) gene expression in normal peripheral blood mononuclear cells via modulation of the NF-kappa beta system, Clin. Vaccine Immunol. CVI, vol.13, pp.319-328, 2006. ,
Anti-inflammatory plant flavonoids and cellular action mechanisms, J. Pharmacol. Sci, vol.96, pp.229-245, 2004. ,
Afanas'ev, I.B. Antioxidant and chelating properties of flavonoids, Adv. Pharmacol. San Diego Calif, vol.38, pp.151-163, 1997. ,
Flavonoid baicalin inhibits HIV-1 infection at the level of viral entry, Biochem. Biophys. Res. Commun, vol.276, pp.534-538, 2000. ,
, Flavonoids from Pterogyne nitens Inhibit Hepatitis C Virus Entry. Sci. Rep. 2017, vol.7, p.16127
Characteristics of flavonoids as potent MERS-CoV 3C-like protease inhibitors, Chem. Biol. Drug Des, vol.94, pp.2023-2030, 2019. ,
Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) inhibition, Bioorg. Med. Chem, vol.18, pp.7940-7947, 2010. ,
Effect of a Toothpaste/Mouthwash Containing Carica papaya Leaf Extract on Interdental Gingival Bleeding: A Randomized Controlled Trial, Int. J. Environ. Res. Public. Health, p.2660, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02308082
Natural Antimicrobials and Oral Microorganisms: A Systematic Review on Herbal Interventions for the Eradication of, Multispecies Oral Biofilms. Front. Microbiol, vol.6, p.1529, 2015. ,
Antimicrobial activity of Citrox bioflavonoid preparations against oral microorganisms, Br. Dent. J, 2011. ,
Antimicrobial activity of novel mouthrinses against planktonic cells and biofilms of pathogenic microorganisms, Microbiol. Discov, 2011. ,
Cyclodextrins in pharmaceutical formulations I: structure and physicochemical properties, formation of complexes, and types of complex, Drug Discov. Today, vol.21, pp.356-362, 2016. ,
, Solubility of Cyclodextrins and Drug/Cyclodextrin Complexes. Mol. Basel Switz, vol.23, p.1161, 2018.
Cyclodextrins in pharmaceutical formulations II: solubilization, binding constant, and complexation efficiency, Drug Discov. Today, vol.21, pp.363-368, 2016. ,
, Questions and answers on cyclodextrins used as excipients in medicinal products for human use, p.10, 2020.
, Int. J. Pharm, vol.453, pp.167-180, 2013.
Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation, J. Pharm. Sci, vol.86, pp.147-162, 1997. ,
Cyclodextrins in delivery systems: Applications, J. Pharm. Bioallied Sci, vol.2, pp.72-79, 2010. ,
Cyclodextrins in drug delivery, Expert Opin. Drug Deliv, vol.2, pp.335-351, 2005. ,
, Emerging Medicines of the New Millennium. Biomolecules, vol.9, p.801, 2019.
Role of the lipid rafts in the life cycle of canine coronavirus, J. Gen. Virol, vol.96, pp.331-337, 2015. ,
Intranasal hydroxypropyl-?-cyclodextrin-adjuvanted influenza vaccine protects against sub-heterologous virus infection, vol.34, pp.3191-3198, 2016. ,
Hydroxypropyl-?-cyclodextrin spikes local inflammation that induces Th2 cell and T follicular helper cell responses to the coadministered antigen, J. Immunol. Baltim. Md, vol.194, pp.2673-2682, 1950. ,
Interactions between cyclodextrins and cellular components: Towards greener medical applications?, Beilstein J. Org. Chem, vol.12, pp.2644-2662, 2016. ,
Modified cyclodextrins as broad-spectrum antivirals, Sci. Adv, vol.6, p.9318, 2020. ,
Amphiphilic cyclodextrin nanoparticles, Int. J. Pharm, vol.531, pp.457-469, 2017. ,
Recent advances and future directions in amphiphilic cyclodextrin nanoparticles, Expert Opin. Drug Deliv, vol.6, pp.1161-1173, 2009. ,